Innovations in cell culture: developing the future

Developing an upstream cell culture process is hard work. We know that you and your team can spend upwards of ten hours a day in the lab setting up and testing a hypothesis. The aim of this event is to provide you with a basis to decide whether or not a particular innovation is right for your company, prior to you and your team spending countless hours in the lab. We’ll do this by providing a forum where leaders will debate the costs versus benefits of selecting certain cell culture process development innovations.

Discussion topics:
Animal derived vs ADCF (animal derived component free), adherent vs suspension cells, custom media vs off-the-shelf, benefits of new non-mammalian platforms

Who should attend:
• Gene therapy researchers
• Research scientists cell culture
• Principal Scientists cell culture
• Upstream process development engineers, scientists, and managers
• MSAT upstream engineers, scientists, and managers